These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8143756)
1. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat. Jacquemin E; Dumont M; Mallet A; Erlinger S Eur J Clin Invest; 1993 Dec; 23(12):794-802. PubMed ID: 8143756 [TBL] [Abstract][Full Text] [Related]
2. Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis. Micheline D; Emmanuel J; Serge E J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):185-91. PubMed ID: 12187295 [TBL] [Abstract][Full Text] [Related]
3. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration. Arrese M; Pizarro M; Solís N; Koenig C; Accatino L Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238 [TBL] [Abstract][Full Text] [Related]
5. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes. Bouchard G; Yousef IM; Tuchweber B Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596 [TBL] [Abstract][Full Text] [Related]
6. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats. Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557 [TBL] [Abstract][Full Text] [Related]
7. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid. Azer SA; Canfield PJ; Stacey NH J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801 [TBL] [Abstract][Full Text] [Related]
8. Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis. Galabert C; Montet JC; Lengrand D; Lecuire A; Sotta C; Figarella C; Chazalette JP J Pediatr; 1992 Jul; 121(1):138-41. PubMed ID: 1352543 [TBL] [Abstract][Full Text] [Related]
9. Effect of alpha-asarone and a derivative on lipids, bile flow and Na+/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat. Garduño-Siciliano L; Labarrios F; Tamariz J; Moreno MG; Chamorro G; Muriel P Fundam Clin Pharmacol; 2007 Feb; 21(1):81-8. PubMed ID: 17227448 [TBL] [Abstract][Full Text] [Related]
10. Effects of iron overload on bile secretion and hepatic porphyrin metabolism in ethinyl estradiol-treated rats. Cantoni L; Di Padova C; Rizzardini M; Dal Fiume D; Graziani A; Rovagnati P; Tritapepe R Toxicology; 1986 Feb; 38(2):187-96. PubMed ID: 3945969 [TBL] [Abstract][Full Text] [Related]
11. Decreased biliary glutathione content is responsible for the decline in bile salt-independent flow induced by ethinyl estradiol in rats. Bouchard G; Yousef IM; Tuchweber B Toxicol Lett; 1994 Dec; 74(3):221-33. PubMed ID: 7871546 [TBL] [Abstract][Full Text] [Related]
12. Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats. Kinbara S; Ishizaki K; Sakakura H; Hirabayashi N; Kasai H; Araki T Scand J Gastroenterol; 1997 Sep; 32(9):947-52. PubMed ID: 9299676 [TBL] [Abstract][Full Text] [Related]
13. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192 [TBL] [Abstract][Full Text] [Related]
14. Biliary permeability during ethinyl estradiol-induced cholestasis studied by segmented retrograde intrabiliary injections in rats. Iqbal S; Mills CO; Elias E J Hepatol; 1985; 1(3):211-9. PubMed ID: 4067253 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Crocenzi FA; Sánchez Pozzi EJ; Pellegrino JM; Favre CO; Rodríguez Garay EA; Mottino AD; Coleman R; Roma MG Hepatology; 2001 Aug; 34(2):329-39. PubMed ID: 11481618 [TBL] [Abstract][Full Text] [Related]
16. Lack of benefit of ursodeoxycholic acid in drug-induced cholestasis in the rat. Hillstrom J; Duane WC; Eckfeldt JH; Furne J; Levitt MD Proc Soc Exp Biol Med; 1992 May; 200(1):122-6. PubMed ID: 1570353 [TBL] [Abstract][Full Text] [Related]
17. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. Stiehl A; Rudolph G; Sauer P; Theilmann L J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol modulates the gut microbiota of cholestasis in pregnant rats. Li Z; Lei L; Ling L; Liu Y; Xiong Z; Shao Y J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193965 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319 [TBL] [Abstract][Full Text] [Related]
20. [Effect of estradiol and ethinyl estradiol on biliary bile acid excretion and bile flow]. Reimold WV; Holtermann M Med Welt; 1982 Dec; 33(48):1744-8. PubMed ID: 7154929 [No Abstract] [Full Text] [Related] [Next] [New Search]